格纯生物 is an industrialization platform focused on pharmaceutical intermediates and related raw materials, including active pharmaceutical ingredients (APIs), medical intermediates, cosmetic ingredients, and food additives. The company conducts research on authentic (dao di) Chinese medicinal materials, carries out preclinical studies of innovative natural drugs, and is building a library of plant monomer compounds. It supplies high-purity natural-product intermediates, chemical constituents of traditional Chinese medicine, reference materials, and natural extracts for new-drug R&D and the TCM industry. The company recently completed a significant Series A financing round of nearly ¥100 million. Proceeds are earmarked to accelerate R&D of cosmetic active ingredients, standardize production lines, and advance market promotion. The article identifies the company with Chengdu in its headline.

Total raised

$14M

Funding rounds

1

Latest round

Series A

Latest activity

Nov 2023